APA (7th ed.) Citation

M, G., B, H., S, A., R, P., A, L., M, O., . . . A, L. (2025). A post-hoc analysis of intravitreal aflibercept-treated nAMD patients from ARIES & ALTAIR: Predicting treatment intervals and frequency for aflibercept treat-and-extend therapy regimen using machine learning. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 263(7), 1885. https://doi.org/10.1007/s00417-025-06812-x

Chicago Style (17th ed.) Citation

M, Gutfleisch, et al. "A Post-hoc Analysis of Intravitreal Aflibercept-treated NAMD Patients from ARIES & ALTAIR: Predicting Treatment Intervals and Frequency for Aflibercept Treat-and-extend Therapy Regimen Using Machine Learning." Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie 263, no. 7 (2025): 1885. https://doi.org/10.1007/s00417-025-06812-x.

MLA (9th ed.) Citation

M, Gutfleisch, et al. "A Post-hoc Analysis of Intravitreal Aflibercept-treated NAMD Patients from ARIES & ALTAIR: Predicting Treatment Intervals and Frequency for Aflibercept Treat-and-extend Therapy Regimen Using Machine Learning." Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie, vol. 263, no. 7, 2025, p. 1885, https://doi.org/10.1007/s00417-025-06812-x.